Clinical trial
Treatment of Keratoconus Using Collagen Cross-Linking By Means of Topical Riboflavin and UV Light.
NCT00841386 is registered in ClinicalTrials.gov with University at Buffalo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Keratoconus Using Collagen Cross-Linking By Means of Topical Riboflavin and UV Light.
- Lead sponsor
- University at Buffalo
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- September 30, 2008
- Completion date
- December 31, 2011
- Enrollment
- 150 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.